InsidersTradesSigma
Track the STRATEC SE stock price and the full directors' dealings record of the company, a publicly traded company based in Germany. Shares are quoted on the DE market, under the oversight of BaFin. Market capitalisation: €308.2m. The latest transaction was disclosed on 21 August 2026 (Other). Among the most active insiders: Leistner, Ralf. Every trade is openly available.
Analysts rate STRATEC SE Buy (bullish), based on 5 analysts. Average price target: €25.60.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
STRATEC SE is a company specializing in the development and manufacturing of analysis systems for the healthcare sector. It is listed on the Frankfurt Stock Exchange (XETR).